Rating History for ORIC Pharmaceuticals (ORIC) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/15/2026 | Corinne Johnson | Upgrade | Buy (Early-Stage Biotech) |
15.00 (N/A) |
8.34 (8.49) |
1.8% | Details |
 |
|||||||
